Skip to content

Clinical study of sudden deafness

Clinical study of sudden deafness

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050883
Enrollment
Unknown
Registered
2021-09-06
Start date
2021-09-06
Completion date
Unknown
Last updated
2022-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sudden deafness

Interventions

Round window membrane drug delivery group:Round window membrane drug delivery
Microcirculation drug group:Microcirculation-improving drugs oral taken for one month

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-75 years; 2. Patients with total deafness diagnosed according to the 2015 guidelines; 3. After 5-7 days of conservative treatment according to the 2015 guidelines, hearing at impaired frequency increased by less than 15 dB on average; 4. The subjects or their legal representatives can understand the purpose of the study, show their compliance with the study protocol, sign informed consent and cooperate with the visitors.

Exclusion criteria

Exclusion criteria: 1. Subjects with serious cardiovascular and cerebrovascular diseases or organ failure; 2. Subjects who have participated in clinical trials of any other drug or medical device within the last 3 months; 3. Subjects deemed unsuitable for the clinical trial by the investigator.

Design outcomes

Primary

MeasureTime frame
Pure tone audiometry(PTA);

Countries

China

Contacts

Public ContactChen Zhengnong

Shanghai Sixth People's Hospital

jassey@126.com+86 21 64834143

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026